Published in Ann Inst Pasteur (Paris) on March 01, 1967
Comparative trials with different decontaminating agents for growing Mycobacterium tuberculosis from sputum specimens. Bull World Health Organ (1968) 0.82
Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res (1999) 7.82
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet (2004) 5.06
Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord (1997) 2.61
Progressive bulbospinal amyotrophy in triple A syndrome with AAAS gene mutation. Neurology (2002) 2.53
Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol (1998) 2.00
Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum (2002) 1.67
Cannabis arteritis revisited--ten new case reports. Angiology (2001) 1.58
Activation of old carbon by erosion of coastal and subsea permafrost in Arctic Siberia. Nature (2012) 1.55
Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort. Eur J Neurol (2011) 1.53
Embolization of two bleeding aneurysms with platinum coils in a patient with polyarteritis nodosa. J Rheumatol (1993) 1.51
Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol (2001) 1.46
McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol (2001) 1.45
Cataract surgery and effectiveness. 1. Variation in costs between different providers of cataract surgery. Acta Ophthalmol Scand (2000) 1.45
Hypothenar hammer syndrome followed by systemic sclerosis. J Rheumatol (2000) 1.42
Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation. Neuroscience (2002) 1.42
A co-operative numerical anaysis of scotochromogenic slowly growing mycobacteria. J Gen Microbiol (1971) 1.40
Early T2 hypointense signal abnormality preceding clinical manifestations of central pontine myelinolysis. Neurology (1994) 1.40
Magnetic resonance imaging in focal myositis. J Rheumatol (1998) 1.39
[Dermatopolymyositis and chronic lymphoid leukemia. Apropos of 2 cases]. Rev Med Interne (1993) 1.39
[Testicular localization of systemic diseases]. Presse Med (1995) 1.39
Clinical drug monitoring by microdialysis: application to levodopa therapy in Parkinson's disease. Br J Clin Pharmacol (1996) 1.39
[Auricular chondritis, malignant glomerulonephritis and pulmonary hemorrhage]. Nephrologie (1991) 1.37
Catquest questionnaire for use in cataract surgery care: description, validity, and reliability. J Cataract Refract Surg (1997) 1.31
Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) (1999) 1.26
[Chorea and systemic lupus erythematosus with circulating anticoagulant. 3 cases]. Rev Neurol (Paris) (1985) 1.25
Catquest questionnaire for use in cataract surgery care: assessment of surgical outcomes. J Cataract Refract Surg (1998) 1.20
Neurologic phenotypes associated with acanthocytosis. Neurology (2007) 1.20
[Study of beta-D-galactosidase of mycobacteria. (Preliminary note)]. Ann Inst Pasteur (Paris) (1966) 1.20
Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rheum (2000) 1.17
Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology (1997) 1.16
Metabolomic profiling by near-infrared spectroscopy as a tool to assess embryo viability: a novel, non-invasive method for embryo selection. Hum Reprod (2008) 1.16
Influence of pulmonary dust load on the development of experimental infection by Mycobacterium kansasii. Nature (1967) 1.14
Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. Am Rev Respir Dis (1986) 1.11
Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry (2004) 1.09
POEMS syndrome: report on six patients with unusual clinical signs, elevated levels of cytokines, macrophage involvement and chromosomal aberrations of bone marrow plasma cells. Leukemia (1997) 1.09
Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J Lipid Res (1989) 1.09
The association: scleroderma-silicosis or Erasmus' syndrome (author's transl). Nouv Presse Med (1977) 1.07
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
Reversible renal failure due to specific infiltration in chronic lymphocytic leukemia. Am J Med (1988) 1.05
Elastase derived elastin peptides: putative autoimmune targets in giant cell arteritis. J Rheumatol (1997) 1.04
Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice. Neuroscience (2003) 1.04
Stimulus-sensitive spinal segmental myoclonus improved with injections of botulinum toxin type A. Mov Disord (1999) 1.03
Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis. A prospective clinical and immunohistologic study in 59 patients. Arthritis Rheum (1993) 1.02
[POEMS syndrome]. Rev Med Interne (1997) 1.02
Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls. J Med Genet (2007) 1.02
Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease. J Med Genet (2009) 1.01
Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis. Clin Exp Rheumatol (2001) 1.01
Haemorrhoid surgery revised. Lancet (2000) 1.00
[Camptocormia: a sign of axial myopathy. Report of 7 cases]. Rev Med Interne (2002) 1.00
Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. Am J Hum Genet (1999) 0.98
Identification of VPS35 mutations replicated in French families with Parkinson disease. Neurology (2012) 0.98
Age-related reduction of human growth hormone-binding sites in the human brain. Brain Res (1993) 0.97
Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France. Neuroepidemiology (2004) 0.97
Experimental study of interactions between pneumoconiosis and mycobacterial infections. Ann N Y Acad Sci (1972) 0.96
Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis. Clin Exp Immunol (2004) 0.95
D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum. Neurosci Lett (1990) 0.94
MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration. Exp Neurol (2004) 0.94
Side-effects of subthalamic stimulation in Parkinson's disease: clinical evolution and predictive factors. Eur J Neurol (2006) 0.94
Subclinical lung inflammation in primary Sjögren's syndrome. Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease. Arthritis Rheum (1987) 0.94
A collaborative evaluation of a rapid automated bacterial identification system: the Autobac IDX. Eur J Clin Microbiol (1984) 0.93
The restless legs syndrome. Prog Neurobiol (2005) 0.93
Role and influence of mycorrhizal fungi on radiocesium accumulation by plants. J Environ Radioact (2007) 0.92
Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin Chem (1987) 0.92
Deviant trafficking of I-Ad mutant molecules is reflected in their peptide binding properties. Eur J Immunol (1999) 0.91
T lymphocyte activation in systemic lupus erythematosus analysed by proliferative response to nucleoplasmic proteins on nitrocellulose immunoblots. Clin Exp Immunol (1989) 0.91
Radioimmunosorbent assay of follicle-stimulating hormone and luteinizing hormone in serum and urine from men and women. Acta Endocrinol Suppl (Copenh) (1973) 0.90
[Choriocarcinoma after transplantation]. J Urol Nephrol (Paris) (1978) 0.90
Pregnancies following treatment with human gonadotropins, with special reference to the problem of multiple births. Am J Obstet Gynecol (1966) 0.90
Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. J Neural Transm (Vienna) (2003) 0.90
Fast orthostatic tremor in Parkinson's disease mimicking primary orthostatic tremor. Mov Disord (2001) 0.89
Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry (2002) 0.88
Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol (1999) 0.88
Olivopontocerebellar pathology in multiple system atrophy. Mov Disord (1996) 0.88
[Multi-infarct disorder presenting as corticobasal degeneration (DCB): vascular pseudo-corticobasal degeneration?]. Rev Neurol (Paris) (2007) 0.88
French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against Mycobacterium avium complex. Antimicrob Agents Chemother (1995) 0.88
Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy). Neuroscience (2000) 0.88
[Generalized mycobacteriosis with hematologic manifestations (fatal infection with Mycobacterium kansasii with myeloid type, leukemoid reaction)]. Rev Tuberc Pneumol (Paris) (1970) 0.87
Characterization of growth hormone binding sites in rat brain. Acta Paediatr Suppl (1994) 0.87
Early expression of E-selectin, tumor necrosis factor alpha, and mast cell infiltration in the salivary glands of patients with systemic sclerosis. Arthritis Rheum (1996) 0.87
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration. Mov Disord (2000) 0.87
Relationship between parity and clinical and biological features in patients with systemic sclerosis. J Rheumatol (2001) 0.86
Association of myelodysplastic syndrome and relapsing polychondritis: further evidence. Leukemia (1995) 0.86
[Silicosis and primary Gougerot-Sjögren syndrome]. Rev Med Interne (1994) 0.86
Sleep disorders in multiple system atrophy. J Neural Transm (Vienna) (2005) 0.86
Respiratory arrest in systemic lupus erythematosus due to phrenic nerve neuropathy. Lupus (2004) 0.86
Experimental evaluation of sensorimotor patterning used with mentally retarded children. Am J Ment Defic (1975) 0.86
Deep brain pallidal stimulation for movement disorders in neuroacanthocytosis. Neurology (2007) 0.86
Growth hormone stimulates the proliferation of cultured chondrocytes from rabbit ear and rat rib growth cartilage. Nature (1983) 0.86
Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patients. Lupus (2004) 0.85
Pharmacokinetics of levamisole in healthy subjects and cancer patients. Eur J Drug Metab Pharmacokinet (1983) 0.85
[Validation of the French language version of the Parkinson's Disease Questionnaire - PDQ-39]. Rev Neurol (Paris) (2002) 0.85
Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice. J Neural Transm (Vienna) (2004) 0.85
Human pituitary prolactin: isolation and characterization of three isohormones with different bioassay and radioimmunoassay activities. Biochim Biophys Acta (1980) 0.85
Evolution of postural stability after subthalamic nucleus stimulation in Parkinson's disease: a combined clinical and posturometric study. Exp Brain Res (2005) 0.85